<DOC>
	<DOCNO>NCT00393991</DOCNO>
	<brief_summary>The purpose study compare efficacy safety fix combination asthma drug FlutiForm HFA MDI two component administer alone , fluticasone propionate formoterol fumarate , placebo adult adolescent patient mild moderate asthma .</brief_summary>
	<brief_title>Comparison New Combination Inhaler ( FlutiForm HFA MDI 100/10 Âµg ) Versus Fluticasone Formoterol Administered Alone , Placebo , Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Ages eligible study : 12 year ; gender eligible study : ; prior steroid use : steroidrequiring steroidfree . History asthma least 12 month . For steroidrequiring patient , document use inhale corticosteroid least 4 week prior Screening Visit For steroidfree patient , history inhale steroid asthma medication least 12 week prior Screening Visit . Demonstrate FEV1 6085 % predict normal value Screening Baseline Visit . Documented reversibility 15 % within 12 month Screening Screening Visit ( 15 % increase preFEV1 level follow albuterol inhalation nebulized albuterol administration ) . Symptoms Asthma Runin Females childbearing potential must negative urine pregnancy test Screening Baseline Visits . Females eligible pregnant lactating , either sterile , use acceptable method contraception . Must otherwise healthy . Provide write informed consent . Wishes minor must respect . Lifethreatening asthma within past year RunIn Period . History systemic corticosteroid medication within 3 month Screening Visit . History omalizumab use within past 6 month . History leukotriene receptor antagonist use , e.g . montelukast , within past week . Current evidence history clinically significant disease abnormality include uncontrolled hypertension , uncontrolled coronary artery disease , congestive heart failure , myocardial infarction , cardiac dysrhythmia . Upper low respiratory infection within 4 week prior Screening Visit RunIn Period . Significant , nonreversible , pulmonary disease ( e.g. , chronic obstructive pulmonary disease [ COPD ] , cystic fibrosis , bronchiectasis ) . Known Human Immunodeficiency Virus ( HIV ) positive status . Smoking history equivalent `` 10 pack year '' . Current smoke history within 12 month prior Screening Visit . Current evidence history alcohol and/or substance abuse within 12 month prior Screening Visit . Patients confine institution</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Fluticasone Propionate</keyword>
	<keyword>Formoterol Fumarate</keyword>
	<keyword>Pressurized meter dose inhaler</keyword>
	<keyword>Hydrofluoroalkane</keyword>
	<keyword>Mild Moderate Asthma</keyword>
</DOC>